Antibody Coupled T Receptor Therapy Market
According to Intent Market Research, the Antibody Coupled T-Receptor Therapy Market is expected to grow from USD 1.9 billion in 2024-e at a CAGR of 15.9% to touch USD 5.2 billion by 2030. The Antibody Coupled T-Receptor Therapy Market is dominated by key players such as, Gilead Sciences, Inc., Novartis AG, Bristol-Myers Squibb, Johnson & Johnson, Roche Holding AG, and AbbVie Inc..